ReP USP - Resultado da busca

Artigo de periodico-carta/editorial
Declining COVID-19 vaccination coverage in Brazil: a global health warning (2025)
Souza, Milena Silva ; Farias, Jéssica Pires ; Amorim, Jaime Henrique ; Ferreira, Luís Carlos de Souza
Source: Journal of Infection. Unidade: ICB
Subjects: MICROBIOLOGIA, COVID-19, VACINAS VIRAIS, VARIAÇÃO GENÉTICA, GENOMAS, VACINAÇÃO
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
SOUZA, Milena Silva et al. Declining COVID-19 vaccination coverage in Brazil: a global health warning. Journal of Infection. Oxford: Instituto de Ciências Biomédicas, Universidade de São Paulo. Disponível em: https://doi.org/10.1016/j.jinf.2025.106418. Acesso em: 27 abr. 2025. , 2025
APA
Souza, M. S., Farias, J. P., Amorim, J. H., & Ferreira, L. C. de S. (2025). Declining COVID-19 vaccination coverage in Brazil: a global health warning. Journal of Infection. Oxford: Instituto de Ciências Biomédicas, Universidade de São Paulo. doi:10.1016/j.jinf.2025.106418
NLM
Souza MS, Farias JP, Amorim JH, Ferreira LC de S. Declining COVID-19 vaccination coverage in Brazil: a global health warning [Internet]. Journal of Infection. 2025 ; 90( 2): 2 .[citado 2025 abr. 27 ] Available from: https://doi.org/10.1016/j.jinf.2025.106418
Vancouver
Souza MS, Farias JP, Amorim JH, Ferreira LC de S. Declining COVID-19 vaccination coverage in Brazil: a global health warning [Internet]. Journal of Infection. 2025 ; 90( 2): 2 .[citado 2025 abr. 27 ] Available from: https://doi.org/10.1016/j.jinf.2025.106418
Artigo de periodico
An update on anti-COVID-19 vaccines and the challenges to protect against new SARS-CoV-2 variants (2025)
Silva, Fábio Mambelli ; Araujo, Ana Carolina Valente Santos Cruz de ; Farias, Jéssica Pires ; Andrade, Kivia Q. de ; Minóprio, Paola Marcella Camargo ; Leite, Luciana Cezar de Cerqueira ; Ferreira, Luís Carlos de Souza ; Oliveira, Sergio Costa
Source: Pathogens. Unidade: ICB
Subjects: MICROBIOLOGIA, IMUNOLOGIA, VACINAS VIRAIS, COVID-19, PANDEMIAS, VARIAÇÃO GENÉTICA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
SILVA, Fábio Mambelli et al. An update on anti-COVID-19 vaccines and the challenges to protect against new SARS-CoV-2 variants. Pathogens, v. 14, n. 1, p. 19 , 2025Tradução . . Disponível em: https://doi.org/10.3390/pathogens14010023. Acesso em: 27 abr. 2025.
APA
Silva, F. M., Araujo, A. C. V. S. C. de, Farias, J. P., Andrade, K. Q. de, Minóprio, P. M. C., Leite, L. C. de C., et al. (2025). An update on anti-COVID-19 vaccines and the challenges to protect against new SARS-CoV-2 variants. Pathogens, 14( 1), 19 . doi:10.3390/pathogens14010023
NLM
Silva FM, Araujo ACVSC de, Farias JP, Andrade KQ de, Minóprio PMC, Leite LC de C, Ferreira LC de S, Oliveira SC. An update on anti-COVID-19 vaccines and the challenges to protect against new SARS-CoV-2 variants [Internet]. Pathogens. 2025 ; 14( 1): 19 .[citado 2025 abr. 27 ] Available from: https://doi.org/10.3390/pathogens14010023
Vancouver
Silva FM, Araujo ACVSC de, Farias JP, Andrade KQ de, Minóprio PMC, Leite LC de C, Ferreira LC de S, Oliveira SC. An update on anti-COVID-19 vaccines and the challenges to protect against new SARS-CoV-2 variants [Internet]. Pathogens. 2025 ; 14( 1): 19 .[citado 2025 abr. 27 ] Available from: https://doi.org/10.3390/pathogens14010023
Artigo de periodico
SpiN-Tec: a T cell-based recombinant vaccine that is safe, immunogenic, and shows high efficacy in experimental models challenged with SARS-CoV-2 variants of concern (2024)
Hojo-Souza, Nathalia Satchiko ; Castro, Júlia T. de; Rivelli, Graziella Gomes ; Azevedo, Patrick Orestes de ; Oliveira, Emiliano Castro de ; Faustino, Lídia Paula ; Salazar, Natália; Bagno, Flávia Fonseca ; Carvalho, Alex F.; Rattis, Bruna Amanda da Cruz ; Lourenço, Karine Lima ; Gomes, Isabela P.; Assis, Bruna Rodrigues Dias; Piccin, Mariela Pires Cabral ; Fonseca, Flavio Guimarães da ; Souza, Renan Pedra de ; Goulart, Gisele Assis Castro ; Santiago, Helton da Costa ; Gazzinelli, Ricardo Tostes ; Silva, João Santana da ; Durigon, Edison Luiz
Source: Vaccine. Unidades: FMRP, ICB
Subjects: MICROBIOLOGIA, CAMUNDONGOS, HAMSTERS, PROTEÍNAS RECOMBINANTES, COVID-19, VACINAS VIRAIS, IMUNOGENICIDADE DA VACINA, IMUNIDADE, ADJUVANTES IMUNOLÓGICOS, ANTICORPOS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
HOJO-SOUZA, Nathalia Satchiko et al. SpiN-Tec: a T cell-based recombinant vaccine that is safe, immunogenic, and shows high efficacy in experimental models challenged with SARS-CoV-2 variants of concern. Vaccine, v. 42, n. 26, p. 16 , 2024Tradução . . Disponível em: https://doi.org/10.1016/j.vaccine.2024.126394. Acesso em: 27 abr. 2025.
APA
Hojo-Souza, N. S., Castro, J. T. de, Rivelli, G. G., Azevedo, P. O. de, Oliveira, E. C. de, Faustino, L. P., et al. (2024). SpiN-Tec: a T cell-based recombinant vaccine that is safe, immunogenic, and shows high efficacy in experimental models challenged with SARS-CoV-2 variants of concern. Vaccine, 42( 26), 16 . doi:10.1016/j.vaccine.2024.126394
NLM
Hojo-Souza NS, Castro JT de, Rivelli GG, Azevedo PO de, Oliveira EC de, Faustino LP, Salazar N, Bagno FF, Carvalho AF, Rattis BA da C, Lourenço KL, Gomes IP, Assis BRD, Piccin MPC, Fonseca FG da, Souza RP de, Goulart GAC, Santiago H da C, Gazzinelli RT, Silva JS da, Durigon EL. SpiN-Tec: a T cell-based recombinant vaccine that is safe, immunogenic, and shows high efficacy in experimental models challenged with SARS-CoV-2 variants of concern [Internet]. Vaccine. 2024 ; 42( 26): 16 .[citado 2025 abr. 27 ] Available from: https://doi.org/10.1016/j.vaccine.2024.126394
Vancouver
Hojo-Souza NS, Castro JT de, Rivelli GG, Azevedo PO de, Oliveira EC de, Faustino LP, Salazar N, Bagno FF, Carvalho AF, Rattis BA da C, Lourenço KL, Gomes IP, Assis BRD, Piccin MPC, Fonseca FG da, Souza RP de, Goulart GAC, Santiago H da C, Gazzinelli RT, Silva JS da, Durigon EL. SpiN-Tec: a T cell-based recombinant vaccine that is safe, immunogenic, and shows high efficacy in experimental models challenged with SARS-CoV-2 variants of concern [Internet]. Vaccine. 2024 ; 42( 26): 16 .[citado 2025 abr. 27 ] Available from: https://doi.org/10.1016/j.vaccine.2024.126394
Artigo de periodico
Influence of bovine pestivirus heterogeneity on serological responses to 10 different commercial vaccine formulation (2024)
Camargo, Luana; Silva, Gustavo Feliciano Resende da; Baccili, Camila Costa ; Flores, Eduardo Furtado ; Gomes, Viviani
Source: Veterinary Microbiology. Unidade: FMVZ
Subjects: BOVINOS, PESTIVIRUS, VACINAS VIRAIS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
CAMARGO, Luana et al. Influence of bovine pestivirus heterogeneity on serological responses to 10 different commercial vaccine formulation. Veterinary Microbiology, v. 296, p. 1-8, 2024Tradução . . Disponível em: https://doi.org/10.1016/j.vetmic.2024.110155. Acesso em: 27 abr. 2025.
APA
Camargo, L., Silva, G. F. R. da, Baccili, C. C., Flores, E. F., & Gomes, V. (2024). Influence of bovine pestivirus heterogeneity on serological responses to 10 different commercial vaccine formulation. Veterinary Microbiology, 296, 1-8. doi:10.1016/j.vetmic.2024.110155
NLM
Camargo L, Silva GFR da, Baccili CC, Flores EF, Gomes V. Influence of bovine pestivirus heterogeneity on serological responses to 10 different commercial vaccine formulation [Internet]. Veterinary Microbiology. 2024 ; 296 1-8.[citado 2025 abr. 27 ] Available from: https://doi.org/10.1016/j.vetmic.2024.110155
Vancouver
Camargo L, Silva GFR da, Baccili CC, Flores EF, Gomes V. Influence of bovine pestivirus heterogeneity on serological responses to 10 different commercial vaccine formulation [Internet]. Veterinary Microbiology. 2024 ; 296 1-8.[citado 2025 abr. 27 ] Available from: https://doi.org/10.1016/j.vetmic.2024.110155
Artigo de periodico
Immune evasion of SARS-CoV-2 omicron subvariants XBB.1.5, XBB.1.16 and EG.5.1 in a cohort of older adults after ChAdOx1-S vaccination and BA.4/5 bivalent Booster (2024)
Machado, Rafael Rahal Guaragna ; Candido, Erika Donizette de Oliveira ; Aguiar, Andressa Simões ; Chalup, Vanessa Nascimento ; Sanches, Patricia Romão ; Dorlass, Erick Gustavo ; Amgarten, Deyvid Emanuel ; Pinho, João Renato Rebello ; Oliveira, Danielle Bruna Leal de
Source: Vaccines. Unidades: FM, ICB, Interunidades em Bioinformática
Subjects: MICROBIOLOGIA, COVID-19, INFECÇÕES POR CORONAVIRUS, VACINAS VIRAIS, VARIAÇÃO GENÉTICA, MUTAÇÃO GENÉTICA, ANTICORPOS, ESTUDOS DE COORTES
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
MACHADO, Rafael Rahal Guaragna et al. Immune evasion of SARS-CoV-2 omicron subvariants XBB.1.5, XBB.1.16 and EG.5.1 in a cohort of older adults after ChAdOx1-S vaccination and BA.4/5 bivalent Booster. Vaccines, v. 12, n. 2, 2024Tradução . . Disponível em: https://doi.org/10.3390/vaccines12020144. Acesso em: 27 abr. 2025.
APA
Machado, R. R. G., Candido, E. D. de O., Aguiar, A. S., Chalup, V. N., Sanches, P. R., Dorlass, E. G., et al. (2024). Immune evasion of SARS-CoV-2 omicron subvariants XBB.1.5, XBB.1.16 and EG.5.1 in a cohort of older adults after ChAdOx1-S vaccination and BA.4/5 bivalent Booster. Vaccines, 12( 2). doi:10.3390/vaccines12020144
NLM
Machado RRG, Candido ED de O, Aguiar AS, Chalup VN, Sanches PR, Dorlass EG, Amgarten DE, Pinho JRR, Oliveira DBL de. Immune evasion of SARS-CoV-2 omicron subvariants XBB.1.5, XBB.1.16 and EG.5.1 in a cohort of older adults after ChAdOx1-S vaccination and BA.4/5 bivalent Booster [Internet]. Vaccines. 2024 ; 12( 2):[citado 2025 abr. 27 ] Available from: https://doi.org/10.3390/vaccines12020144
Vancouver
Machado RRG, Candido ED de O, Aguiar AS, Chalup VN, Sanches PR, Dorlass EG, Amgarten DE, Pinho JRR, Oliveira DBL de. Immune evasion of SARS-CoV-2 omicron subvariants XBB.1.5, XBB.1.16 and EG.5.1 in a cohort of older adults after ChAdOx1-S vaccination and BA.4/5 bivalent Booster [Internet]. Vaccines. 2024 ; 12( 2):[citado 2025 abr. 27 ] Available from: https://doi.org/10.3390/vaccines12020144
Artigo de periodico
Maternal immunization in women living with HIV (2024)
Dauby, Nicolas; Gagneux-Brunon, Amandine; Martin, Charlotte; Mussi-Pinhata, Marisa Márcia ; Goetghebuer, Tessa
Source: Aids. Unidade: FMRP
Subjects: COVID-19, INFLUENZA, INFECÇÕES POR HIV, IMUNIZAÇÃO, VACINAS VIRAIS, COQUELUCHE
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
DAUBY, Nicolas et al. Maternal immunization in women living with HIV. Aids, v. 38 , n. 2, p. 137-144, 2024Tradução . . Disponível em: https://doi.org/10.1097/QAD.0000000000003758. Acesso em: 27 abr. 2025.
APA
Dauby, N., Gagneux-Brunon, A., Martin, C., Mussi-Pinhata, M. M., & Goetghebuer, T. (2024). Maternal immunization in women living with HIV. Aids, 38 ( 2), 137-144. doi:10.1097/QAD.0000000000003758
NLM
Dauby N, Gagneux-Brunon A, Martin C, Mussi-Pinhata MM, Goetghebuer T. Maternal immunization in women living with HIV [Internet]. Aids. 2024 ; 38 ( 2): 137-144.[citado 2025 abr. 27 ] Available from: https://doi.org/10.1097/QAD.0000000000003758
Vancouver
Dauby N, Gagneux-Brunon A, Martin C, Mussi-Pinhata MM, Goetghebuer T. Maternal immunization in women living with HIV [Internet]. Aids. 2024 ; 38 ( 2): 137-144.[citado 2025 abr. 27 ] Available from: https://doi.org/10.1097/QAD.0000000000003758
Artigo de periodico-divulgacao
As particularidades do vírus da dengue (2024)
Brandão, Paulo Eduardo
Source: Veja Saúde. Unidade: FMVZ
Subjects: VÍRUS DA DENGUE, DENGUE, VACINAS VIRAIS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
BRANDÃO, Paulo Eduardo. As particularidades do vírus da dengue. Veja Saúde. São Paulo: Faculdade de Medicina Veterinária e Zootecnia, Universidade de São Paulo. Disponível em: https://saude.abril.com.br/coluna/virosfera/as-particularidades-do-virus-da-dengue/. Acesso em: 27 abr. 2025. , 2024
APA
Brandão, P. E. (2024). As particularidades do vírus da dengue. Veja Saúde. São Paulo: Faculdade de Medicina Veterinária e Zootecnia, Universidade de São Paulo. Recuperado de https://saude.abril.com.br/coluna/virosfera/as-particularidades-do-virus-da-dengue/
NLM
Brandão PE. As particularidades do vírus da dengue [Internet]. Veja Saúde. 2024 ; 6 fe 2024[citado 2025 abr. 27 ] Available from: https://saude.abril.com.br/coluna/virosfera/as-particularidades-do-virus-da-dengue/
Vancouver
Brandão PE. As particularidades do vírus da dengue [Internet]. Veja Saúde. 2024 ; 6 fe 2024[citado 2025 abr. 27 ] Available from: https://saude.abril.com.br/coluna/virosfera/as-particularidades-do-virus-da-dengue/
Artigo de periodico
Enhanced immunogenicity and protective effects against SARS-CoV-2 following immunization with a recombinant RBD-IgG chimeric protein (2024)
Silva, Mariângela de Oliveira ; Castro-Amarante, Maria Fernanda ; Carvalho, Alexia Adrianne Venceslau Brito ; Almeida, Bianca da Silva; Daher, Isabela Pazotti ; Souza-Silva, Guilherme Antonio de ; Yamamoto, Marcio Massao ; Koike, Gabriela ; Souza, Edmarcia Elisa de ; Wrenger, Carsten ; Ferreira, Luis Carlos de Souza ; Boscardin, Silvia Beatriz
Source: Vaccines. Unidades: ICB, FM
Subjects: PARASITOLOGIA, MICROBIOLOGIA, PROTEÍNAS RECOMBINANTES, PROTEÍNAS SANGUÍNEAS, ANTICORPOS, IMUNOGENICIDADE DA VACINA, IMUNOGENÉTICA, IMUNOGLOBULINAS, COVID-19, VACINAS VIRAIS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
SILVA, Mariângela de Oliveira et al. Enhanced immunogenicity and protective effects against SARS-CoV-2 following immunization with a recombinant RBD-IgG chimeric protein. Vaccines, v. 12, n. 4, p. 14 , 2024Tradução . . Disponível em: https://doi.org/10.3390/vaccines12040356. Acesso em: 27 abr. 2025.
APA
Silva, M. de O., Castro-Amarante, M. F., Carvalho, A. A. V. B., Almeida, B. da S., Daher, I. P., Souza-Silva, G. A. de, et al. (2024). Enhanced immunogenicity and protective effects against SARS-CoV-2 following immunization with a recombinant RBD-IgG chimeric protein. Vaccines, 12( 4), 14 . doi:10.3390/vaccines12040356
NLM
Silva M de O, Castro-Amarante MF, Carvalho AAVB, Almeida B da S, Daher IP, Souza-Silva GA de, Yamamoto MM, Koike G, Souza EE de, Wrenger C, Ferreira LC de S, Boscardin SB. Enhanced immunogenicity and protective effects against SARS-CoV-2 following immunization with a recombinant RBD-IgG chimeric protein [Internet]. Vaccines. 2024 ; 12( 4): 14 .[citado 2025 abr. 27 ] Available from: https://doi.org/10.3390/vaccines12040356
Vancouver
Silva M de O, Castro-Amarante MF, Carvalho AAVB, Almeida B da S, Daher IP, Souza-Silva GA de, Yamamoto MM, Koike G, Souza EE de, Wrenger C, Ferreira LC de S, Boscardin SB. Enhanced immunogenicity and protective effects against SARS-CoV-2 following immunization with a recombinant RBD-IgG chimeric protein [Internet]. Vaccines. 2024 ; 12( 4): 14 .[citado 2025 abr. 27 ] Available from: https://doi.org/10.3390/vaccines12040356
Artigo de periodico
Layer-by-Layer assembly of polymeric nanoparticles with heparin-RBD complexes as an adjuvant for SARS-Cov-2 protein-based vaccines (2024)
Delechiave, Giovanne ; Silva, Mariângela de Oliveira ; Amarante, Maria Fernanda de Castro ; Camarena, Denisse Esther Mallaupoma ; Carvalho, Aléxia Adrianne Venceslau ; Catalani, Luiz Henrique ; Ferreira, Luis Carlos de Souza
Source: ACS Applied Nano Materials. Unidades: IQ, ICB, FCF
Subjects: MICROBIOLOGIA, COVID-19, VACINAS VIRAIS, NANOPARTÍCULAS, ADJUVANTES IMUNOLÓGICOS, PROTEÍNAS RECOMBINANTES, POLISSACARÍDEOS BACTERIANOS, GLICOSAMINOGLICANAS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
DELECHIAVE, Giovanne et al. Layer-by-Layer assembly of polymeric nanoparticles with heparin-RBD complexes as an adjuvant for SARS-Cov-2 protein-based vaccines. ACS Applied Nano Materials, v. 7, n. 4, p. 4068-4077, 2024Tradução . . Disponível em: https://doi.org/10.1021/acsanm.3c05644. Acesso em: 27 abr. 2025.
APA
Delechiave, G., Silva, M. de O., Amarante, M. F. de C., Camarena, D. E. M., Carvalho, A. A. V., Catalani, L. H., & Ferreira, L. C. de S. (2024). Layer-by-Layer assembly of polymeric nanoparticles with heparin-RBD complexes as an adjuvant for SARS-Cov-2 protein-based vaccines. ACS Applied Nano Materials, 7( 4), 4068-4077. doi:10.1021/acsanm.3c05644
NLM
Delechiave G, Silva M de O, Amarante MF de C, Camarena DEM, Carvalho AAV, Catalani LH, Ferreira LC de S. Layer-by-Layer assembly of polymeric nanoparticles with heparin-RBD complexes as an adjuvant for SARS-Cov-2 protein-based vaccines [Internet]. ACS Applied Nano Materials. 2024 ; 7( 4): 4068-4077.[citado 2025 abr. 27 ] Available from: https://doi.org/10.1021/acsanm.3c05644
Vancouver
Delechiave G, Silva M de O, Amarante MF de C, Camarena DEM, Carvalho AAV, Catalani LH, Ferreira LC de S. Layer-by-Layer assembly of polymeric nanoparticles with heparin-RBD complexes as an adjuvant for SARS-Cov-2 protein-based vaccines [Internet]. ACS Applied Nano Materials. 2024 ; 7( 4): 4068-4077.[citado 2025 abr. 27 ] Available from: https://doi.org/10.1021/acsanm.3c05644
Artigo de periodico
Neutralizing antibody response after immunization with a COVID-19 bivalent vaccine: insights to the future (2024)
Souza, Milena Silva ; Farias, Jéssica Pires ; Santos, Robert Andreata ; Silva, Marianne Pereira; Brito, Ruth Dálety da Silva; Silva, Marcia Duarte Barbosa da; Peter, Cristina Mendes; Cirilo, Marcus Vinicius de França ; Luiz, Wilson Barros ; Birbrair, Alexander ; Vidal, Paloma Oliveira ; Amarante, Maria Fernanda Castro ; Candido, Erika Donizette de Oliveira ; Munhoz, Aldilene Silva ; Malta, Fernanda de Mello ; Dorlass, Erick Gustavo ; Machado, Rafael Rahal Guaragna ; Pinho, Joao Renato Rebello ; Oliveira, Danielle Bruna Leal de ; Maricato, Juliana Terzi ; Braconi, Carla Torres ; Janini, Luiz Mário Ramos ; Amorim, Jaime Henrique ; Ferreira, Luis Carlos de Souza ; Durigon, Edison Luiz
Source: Journal of Medical Virology. Unidade: ICB
Subjects: MICROBIOLOGIA, EPITOPOS, COVID-19, VACINAS VIRAIS, GLICOPROTEÍNAS DA MEMBRANA, ANTICORPOS, VARIAÇÃO GENÉTICA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
SOUZA, Milena Silva et al. Neutralizing antibody response after immunization with a COVID-19 bivalent vaccine: insights to the future. Journal of Medical Virology, v. 96, n. 2, p. 9 , 2024Tradução . . Disponível em: https://doi.org/10.1002/jmv.29416. Acesso em: 27 abr. 2025.
APA
Souza, M. S., Farias, J. P., Santos, R. A., Silva, M. P., Brito, R. D. da S., Silva, M. D. B. da, et al. (2024). Neutralizing antibody response after immunization with a COVID-19 bivalent vaccine: insights to the future. Journal of Medical Virology, 96( 2), 9 . doi:10.1002/jmv.29416
NLM
Souza MS, Farias JP, Santos RA, Silva MP, Brito RD da S, Silva MDB da, Peter CM, Cirilo MV de F, Luiz WB, Birbrair A, Vidal PO, Amarante MFC, Candido ED de O, Munhoz AS, Malta F de M, Dorlass EG, Machado RRG, Pinho JRR, Oliveira DBL de, Maricato JT, Braconi CT, Janini LMR, Amorim JH, Ferreira LC de S, Durigon EL. Neutralizing antibody response after immunization with a COVID-19 bivalent vaccine: insights to the future [Internet]. Journal of Medical Virology. 2024 ; 96( 2): 9 .[citado 2025 abr. 27 ] Available from: https://doi.org/10.1002/jmv.29416
Vancouver
Souza MS, Farias JP, Santos RA, Silva MP, Brito RD da S, Silva MDB da, Peter CM, Cirilo MV de F, Luiz WB, Birbrair A, Vidal PO, Amarante MFC, Candido ED de O, Munhoz AS, Malta F de M, Dorlass EG, Machado RRG, Pinho JRR, Oliveira DBL de, Maricato JT, Braconi CT, Janini LMR, Amorim JH, Ferreira LC de S, Durigon EL. Neutralizing antibody response after immunization with a COVID-19 bivalent vaccine: insights to the future [Internet]. Journal of Medical Virology. 2024 ; 96( 2): 9 .[citado 2025 abr. 27 ] Available from: https://doi.org/10.1002/jmv.29416
Artigo de periodico
Replication, safety and immunogenicity of the vectored Ebola vaccine rVSV-ΔG-ZEBOV-GP in a sub- Saharan African paediatric population: a randomised controlled, open-label trial in children aged 1-12 years living in Lambaréné, Gabon (2024)
Alabi, Ayodele; Kokou, Kossiwa; Mahmoudou, Saidou; Kavishna, Ranmali; Nakka, Sravya S; Rothenberger, Sylvia; Musangomunei, Fungai P; Olubiyi, Bisola F; Bie-Ondo, Juste C; Kabwende, Anita L; Velavan, Thirumalaisamy P; Medaglini, Donata ; Nakaya, Helder Takashi Imoto ; Engler, Olivier; Harandi, Ali M; Siegrist, Claire Anne ; Kremsner, Peter G; Agnandji, Selidji T
Source: Journal of Infection. Unidade: FCF
Subjects: VACINAS VIRAIS, VÍRUS EBOLA, ANTICORPOS, CRIANÇAS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
ALABI, Ayodele et al. Replication, safety and immunogenicity of the vectored Ebola vaccine rVSV-ΔG-ZEBOV-GP in a sub- Saharan African paediatric population: a randomised controlled, open-label trial in children aged 1-12 years living in Lambaréné, Gabon. Journal of Infection, v. 89, n. 4, p. 1-33 art. 106237, 2024Tradução . . Disponível em: https://dx.doi.org/10.1016/j.jinf.2024.106237. Acesso em: 27 abr. 2025.
APA
Alabi, A., Kokou, K., Mahmoudou, S., Kavishna, R., Nakka, S. S., Rothenberger, S., et al. (2024). Replication, safety and immunogenicity of the vectored Ebola vaccine rVSV-ΔG-ZEBOV-GP in a sub- Saharan African paediatric population: a randomised controlled, open-label trial in children aged 1-12 years living in Lambaréné, Gabon. Journal of Infection, 89( 4), 1-33 art. 106237. doi:10.1016/j.jinf.2024.106237
NLM
Alabi A, Kokou K, Mahmoudou S, Kavishna R, Nakka SS, Rothenberger S, Musangomunei FP, Olubiyi BF, Bie-Ondo JC, Kabwende AL, Velavan TP, Medaglini D, Nakaya HTI, Engler O, Harandi AM, Siegrist CA, Kremsner PG, Agnandji ST. Replication, safety and immunogenicity of the vectored Ebola vaccine rVSV-ΔG-ZEBOV-GP in a sub- Saharan African paediatric population: a randomised controlled, open-label trial in children aged 1-12 years living in Lambaréné, Gabon [Internet]. Journal of Infection. 2024 ; 89( 4): 1-33 art. 106237.[citado 2025 abr. 27 ] Available from: https://dx.doi.org/10.1016/j.jinf.2024.106237
Vancouver
Alabi A, Kokou K, Mahmoudou S, Kavishna R, Nakka SS, Rothenberger S, Musangomunei FP, Olubiyi BF, Bie-Ondo JC, Kabwende AL, Velavan TP, Medaglini D, Nakaya HTI, Engler O, Harandi AM, Siegrist CA, Kremsner PG, Agnandji ST. Replication, safety and immunogenicity of the vectored Ebola vaccine rVSV-ΔG-ZEBOV-GP in a sub- Saharan African paediatric population: a randomised controlled, open-label trial in children aged 1-12 years living in Lambaréné, Gabon [Internet]. Journal of Infection. 2024 ; 89( 4): 1-33 art. 106237.[citado 2025 abr. 27 ] Available from: https://dx.doi.org/10.1016/j.jinf.2024.106237
Artigo de periodico-divulgacao
Mpox: o que sabemos sobre a nova linhagem quepreocupa o mundo (2024)
Brandão, Paulo Eduardo
Source: Veja Saúde. Unidade: FMVZ
Subjects: POXVIRIDAE, VACINAS VIRAIS, TRANSMISSÃO DE DOENÇAS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
BRANDÃO, Paulo Eduardo. Mpox: o que sabemos sobre a nova linhagem quepreocupa o mundo. Veja Saúde. São Paulo: Faculdade de Medicina Veterinária e Zootecnia, Universidade de São Paulo. Disponível em: https://saude.abril.com.br/coluna/virosfera/mpox-o-que-sabemos-sobre-a-nova-linhagem-que-preocupa-o-mundo/. Acesso em: 27 abr. 2025. , 2024
APA
Brandão, P. E. (2024). Mpox: o que sabemos sobre a nova linhagem quepreocupa o mundo. Veja Saúde. São Paulo: Faculdade de Medicina Veterinária e Zootecnia, Universidade de São Paulo. Recuperado de https://saude.abril.com.br/coluna/virosfera/mpox-o-que-sabemos-sobre-a-nova-linhagem-que-preocupa-o-mundo/
NLM
Brandão PE. Mpox: o que sabemos sobre a nova linhagem quepreocupa o mundo [Internet]. Veja Saúde. 2024 ;[citado 2025 abr. 27 ] Available from: https://saude.abril.com.br/coluna/virosfera/mpox-o-que-sabemos-sobre-a-nova-linhagem-que-preocupa-o-mundo/
Vancouver
Brandão PE. Mpox: o que sabemos sobre a nova linhagem quepreocupa o mundo [Internet]. Veja Saúde. 2024 ;[citado 2025 abr. 27 ] Available from: https://saude.abril.com.br/coluna/virosfera/mpox-o-que-sabemos-sobre-a-nova-linhagem-que-preocupa-o-mundo/
Artigo de periodico
Salivary assessment of the immune/inflammatory responses and oxidative stress in older adults vaccinated with CoronaVac or ChadOx-1 (2024)
Vieira, Jeniffer; Oliveira, Thiago Vinícius Vieira de; Queiroz, Lorrayne Rithielle Rocha; Camargo, Camila Tussato Soares ; Nardy, Ariane ; Monteiro, Fernanda Rodrigues ; Amaral, Jonatas Bussador do ; Paixão, Vitória ; Vaisberg, Mauro Walter ; Amirato, Gislene Rocha ; Santos, Carlos André Freitas dos ; Oliveira, Danielle Bruna Leal de ; Aguiar, Andressa Simões ; Alvares-Saraiva, Anuska Marcelino ; Heller, Débora ; Mantoanelli, Patricia Gabriela Viana ; Siqueira, Michelle Foigel; Nali, Luiz Henrique da Silva ; Bachi, André Luis Lacerda ; Durigon, Edison Luiz
Source: BMC Geriatrics. Unidade: ICB
Subjects: MICROBIOLOGIA, VACINAS VIRAIS, COVID-19, SALIVA, IDOSOS, CITOCINAS, IMUNOGLOBULINAS, IMUNOGENICIDADE DA VACINA, INFLAMAÇÃO, AGENTES ANTIMICROBIANOS, PEPTÍDEOS, ESTRESSE OXIDATIVO
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
VIEIRA, Jeniffer et al. Salivary assessment of the immune/inflammatory responses and oxidative stress in older adults vaccinated with CoronaVac or ChadOx-1. BMC Geriatrics, v. 24, n. 1, p. 17 , 2024Tradução . . Disponível em: https://doi.org/10.1186/s12877-024-05357-8. Acesso em: 27 abr. 2025.
APA
Vieira, J., Oliveira, T. V. V. de, Queiroz, L. R. R., Camargo, C. T. S., Nardy, A., Monteiro, F. R., et al. (2024). Salivary assessment of the immune/inflammatory responses and oxidative stress in older adults vaccinated with CoronaVac or ChadOx-1. BMC Geriatrics, 24( 1), 17 . doi:10.1186/s12877-024-05357-8
NLM
Vieira J, Oliveira TVV de, Queiroz LRR, Camargo CTS, Nardy A, Monteiro FR, Amaral JB do, Paixão V, Vaisberg MW, Amirato GR, Santos CAF dos, Oliveira DBL de, Aguiar AS, Alvares-Saraiva AM, Heller D, Mantoanelli PGV, Siqueira MF, Nali LH da S, Bachi ALL, Durigon EL. Salivary assessment of the immune/inflammatory responses and oxidative stress in older adults vaccinated with CoronaVac or ChadOx-1 [Internet]. BMC Geriatrics. 2024 ; 24( 1): 17 .[citado 2025 abr. 27 ] Available from: https://doi.org/10.1186/s12877-024-05357-8
Vancouver
Vieira J, Oliveira TVV de, Queiroz LRR, Camargo CTS, Nardy A, Monteiro FR, Amaral JB do, Paixão V, Vaisberg MW, Amirato GR, Santos CAF dos, Oliveira DBL de, Aguiar AS, Alvares-Saraiva AM, Heller D, Mantoanelli PGV, Siqueira MF, Nali LH da S, Bachi ALL, Durigon EL. Salivary assessment of the immune/inflammatory responses and oxidative stress in older adults vaccinated with CoronaVac or ChadOx-1 [Internet]. BMC Geriatrics. 2024 ; 24( 1): 17 .[citado 2025 abr. 27 ] Available from: https://doi.org/10.1186/s12877-024-05357-8
Artigo de periodico
Characteristics of emerging new autoimmune diseases after COVID-19 vaccination: a sub-study by the COVAD group (2024)
Shumnalieva, Russka; Ravichandran, Naveen; Hannah, Jennifer; Javaid, Mahnoor; Darooka, Naitica; Roy, Debaditya; Gonzalez, Daniel E; Velikova, Tsvetelina; Milchert, Marcin; Shinjo, Samuel Katsuyuki
Source: International journal of rheumatic diseases. Unidade: FM
Subjects: DOENÇAS AUTOIMUNES, VACINAS VIRAIS, VACINAÇÃO, COVID-19, MELATONINA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
SHUMNALIEVA, Russka et al. Characteristics of emerging new autoimmune diseases after COVID-19 vaccination: a sub-study by the COVAD group. International journal of rheumatic diseases, v. 27, n. 5, 2024Tradução . . Disponível em: https://observatorio.fm.usp.br/handle/OPI/76834. Acesso em: 27 abr. 2025.
APA
Shumnalieva, R., Ravichandran, N., Hannah, J., Javaid, M., Darooka, N., Roy, D., et al. (2024). Characteristics of emerging new autoimmune diseases after COVID-19 vaccination: a sub-study by the COVAD group. International journal of rheumatic diseases, 27( 5). doi:10.1111/1756-185X.15178
NLM
Shumnalieva R, Ravichandran N, Hannah J, Javaid M, Darooka N, Roy D, Gonzalez DE, Velikova T, Milchert M, Shinjo SK. Characteristics of emerging new autoimmune diseases after COVID-19 vaccination: a sub-study by the COVAD group [Internet]. International journal of rheumatic diseases. 2024 ; 27( 5):[citado 2025 abr. 27 ] Available from: https://observatorio.fm.usp.br/handle/OPI/76834
Vancouver
Shumnalieva R, Ravichandran N, Hannah J, Javaid M, Darooka N, Roy D, Gonzalez DE, Velikova T, Milchert M, Shinjo SK. Characteristics of emerging new autoimmune diseases after COVID-19 vaccination: a sub-study by the COVAD group [Internet]. International journal of rheumatic diseases. 2024 ; 27( 5):[citado 2025 abr. 27 ] Available from: https://observatorio.fm.usp.br/handle/OPI/76834
Artigo de periodico
A self-adjuvanted VLPs-based Covid-19 vaccine proven versatile, safe, and highly protective (2024)
Vuitika, Larissa ; Cortês, Nelson de Angelis ; Malaquias, Vanessa Barbosa ; Silva, Jaqueline Dinis Qeiroz; Lira, Aline Aparecida de lima ; Prates-Syed, Wasim Aluisio ; Schimke, Lena Friederike ; Luz, Daniela ; Durães-Carvalho, Ricardo ; Cabral-Marques, Otávio ; Camara, Niels Olsen Saraiva ; Balan, Andrea ; Cabral-Miranda, Gustavo ; Hirata, Mario Hiroyuki ; Krieger, Jose Eduardo
Source: Scientific Reports. Unidades: ICB, FM, FCF, Interunidades em Biotecnologia
Subjects: MICROBIOLOGIA, IMUNOLOGIA, VACINAÇÃO, VACINAS VIRAIS, ANTICORPOS, CORONAVIRUS, ADJUVANTES IMUNOLÓGICOS, MICROSCOPIA ELETRÔNICA, GLICOPROTEÍNAS DA MEMBRANA, ENDOTOXINAS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
VUITIKA, Larissa et al. A self-adjuvanted VLPs-based Covid-19 vaccine proven versatile, safe, and highly protective. Scientific Reports, v. 14, p. 17 , 2024Tradução . . Disponível em: https://doi.org/10.1038/s41598-024-76163-w. Acesso em: 27 abr. 2025.
APA
Vuitika, L., Cortês, N. de A., Malaquias, V. B., Silva, J. D. Q., Lira, A. A. de lima, Prates-Syed, W. A., et al. (2024). A self-adjuvanted VLPs-based Covid-19 vaccine proven versatile, safe, and highly protective. Scientific Reports, 14, 17 . doi:10.1038/s41598-024-76163-w
NLM
Vuitika L, Cortês N de A, Malaquias VB, Silva JDQ, Lira AA de lima, Prates-Syed WA, Schimke LF, Luz D, Durães-Carvalho R, Cabral-Marques O, Camara NOS, Balan A, Cabral-Miranda G, Hirata MH, Krieger JE. A self-adjuvanted VLPs-based Covid-19 vaccine proven versatile, safe, and highly protective [Internet]. Scientific Reports. 2024 ; 14 17 .[citado 2025 abr. 27 ] Available from: https://doi.org/10.1038/s41598-024-76163-w
Vancouver
Vuitika L, Cortês N de A, Malaquias VB, Silva JDQ, Lira AA de lima, Prates-Syed WA, Schimke LF, Luz D, Durães-Carvalho R, Cabral-Marques O, Camara NOS, Balan A, Cabral-Miranda G, Hirata MH, Krieger JE. A self-adjuvanted VLPs-based Covid-19 vaccine proven versatile, safe, and highly protective [Internet]. Scientific Reports. 2024 ; 14 17 .[citado 2025 abr. 27 ] Available from: https://doi.org/10.1038/s41598-024-76163-w
Tese (Doutorado)
A Integrative systems analysis of the immune response to dengue virus (2024)
Plaça, Desireé Rodrigues ; Marques, Otavio Cabral (Orientador)
Unidade: FCF
Subjects: IMUNOLOGIA, IMUNIZAÇÃO, AUTOIMUNIDADE, VÍRUS DA DENGUE, INTERFERONS, DIFERENCIAÇÃO CELULAR, BIOMARCADORES, VACINAS VIRAIS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
PLAÇA, Desireé Rodrigues. A Integrative systems analysis of the immune response to dengue virus. 2024. Tese (Doutorado) – Universidade de São Paulo, São Paulo, 2024. Disponível em: https://www.teses.usp.br/teses/disponiveis/9/9142/tde-10102024-104755/. Acesso em: 27 abr. 2025.
APA
Plaça, D. R. (2024). A Integrative systems analysis of the immune response to dengue virus (Tese (Doutorado). Universidade de São Paulo, São Paulo. Recuperado de https://www.teses.usp.br/teses/disponiveis/9/9142/tde-10102024-104755/
NLM
Plaça DR. A Integrative systems analysis of the immune response to dengue virus [Internet]. 2024 ;[citado 2025 abr. 27 ] Available from: https://www.teses.usp.br/teses/disponiveis/9/9142/tde-10102024-104755/
Vancouver
Plaça DR. A Integrative systems analysis of the immune response to dengue virus [Internet]. 2024 ;[citado 2025 abr. 27 ] Available from: https://www.teses.usp.br/teses/disponiveis/9/9142/tde-10102024-104755/
Artigo de periodico
Anamnestic response against bovine viral diarrhea virus and bovine herpesvirus type 1 in young Holstein heifers vaccinated with four different commercial formulations (2024)
Gomes, Viviani ; Baccili, Camila Costa ; Marques, Raquel Sousa ; Soriano, Sérgio ; Pedroso, Natália Hettwer ; Flores, Eduardo Furtado
Source: Ciência Rural. Unidade: FMVZ
Subjects: VÍRUS DA DIARREIA BOVINA, VACINAS VIRAIS, BOVINOS, HERPESVIRIDAE
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
GOMES, Viviani et al. Anamnestic response against bovine viral diarrhea virus and bovine herpesvirus type 1 in young Holstein heifers vaccinated with four different commercial formulations. Ciência Rural, v. 54, n. 2, p. 1-8, 2024Tradução . . Disponível em: https://doi.org/10.1590/0103-8478cr20220364. Acesso em: 27 abr. 2025.
APA
Gomes, V., Baccili, C. C., Marques, R. S., Soriano, S., Pedroso, N. H., & Flores, E. F. (2024). Anamnestic response against bovine viral diarrhea virus and bovine herpesvirus type 1 in young Holstein heifers vaccinated with four different commercial formulations. Ciência Rural, 54( 2), 1-8. doi:10.1590/0103-8478cr20220364
NLM
Gomes V, Baccili CC, Marques RS, Soriano S, Pedroso NH, Flores EF. Anamnestic response against bovine viral diarrhea virus and bovine herpesvirus type 1 in young Holstein heifers vaccinated with four different commercial formulations [Internet]. Ciência Rural. 2024 ; 54( 2): 1-8.[citado 2025 abr. 27 ] Available from: https://doi.org/10.1590/0103-8478cr20220364
Vancouver
Gomes V, Baccili CC, Marques RS, Soriano S, Pedroso NH, Flores EF. Anamnestic response against bovine viral diarrhea virus and bovine herpesvirus type 1 in young Holstein heifers vaccinated with four different commercial formulations [Internet]. Ciência Rural. 2024 ; 54( 2): 1-8.[citado 2025 abr. 27 ] Available from: https://doi.org/10.1590/0103-8478cr20220364
Artigo de periodico
Immunological signatures unveiled by integrative systems vaccinology characterization of dengue vaccination trials and natural infection (2024)
Plaça, Desireé Rodrigues ; Fonseca, Dennyson Leandro Mathias ; Marques, Alexandre Henrique Carvalho ; Pour, Shahab Zaki ; Usuda, Julia Nakanishi ; Baiocchi, Gabriela Crispim ; Prado, Caroline Aliane De Souza ; Salgado, Ranieri Coelho ; Filgueiras, Igor Salerno ; Freire, Paula Paccielli ; Miranda, Gustavo Cabral de ; Catar, Rusan ; Moll, Guido ; Jurisica, Igor ; Giil, Lasse Melvaer ; Rivino, Laura ; Ochs, Hans Dieter ; Miranda, Gustavo Cabral de ; Schimke, Lena Friederike ; Rocha, Vanderson Geraldo ; Camara, Niels Olsen Saraiva ; Calich, Vera Lúcia Garcia ; Marques, Otavio Cabral
Source: Frontiers in Immunology. Unidades: FM, ICB, FCF
Subjects: IMUNOLOGIA, DENGUE, INFECÇÕES POR ARBOVIRUS, VACINAS VIRAIS, VACINAÇÃO, RESPOSTAS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
PLAÇA, Desireé Rodrigues et al. Immunological signatures unveiled by integrative systems vaccinology characterization of dengue vaccination trials and natural infection. Frontiers in Immunology, v. 15, p. 17 , 2024Tradução . . Disponível em: https://doi.org/10.3389/fimmu.2024.1282754. Acesso em: 27 abr. 2025.
APA
Plaça, D. R., Fonseca, D. L. M., Marques, A. H. C., Pour, S. Z., Usuda, J. N., Baiocchi, G. C., et al. (2024). Immunological signatures unveiled by integrative systems vaccinology characterization of dengue vaccination trials and natural infection. Frontiers in Immunology, 15, 17 . doi:10.3389/fimmu.2024.1282754
NLM
Plaça DR, Fonseca DLM, Marques AHC, Pour SZ, Usuda JN, Baiocchi GC, Prado CADS, Salgado RC, Filgueiras IS, Freire PP, Miranda GC de, Catar R, Moll G, Jurisica I, Giil LM, Rivino L, Ochs HD, Miranda GC de, Schimke LF, Rocha VG, Camara NOS, Calich VLG, Marques OC. Immunological signatures unveiled by integrative systems vaccinology characterization of dengue vaccination trials and natural infection [Internet]. Frontiers in Immunology. 2024 ; 15 17 .[citado 2025 abr. 27 ] Available from: https://doi.org/10.3389/fimmu.2024.1282754.
Vancouver
Plaça DR, Fonseca DLM, Marques AHC, Pour SZ, Usuda JN, Baiocchi GC, Prado CADS, Salgado RC, Filgueiras IS, Freire PP, Miranda GC de, Catar R, Moll G, Jurisica I, Giil LM, Rivino L, Ochs HD, Miranda GC de, Schimke LF, Rocha VG, Camara NOS, Calich VLG, Marques OC. Immunological signatures unveiled by integrative systems vaccinology characterization of dengue vaccination trials and natural infection [Internet]. Frontiers in Immunology. 2024 ; 15 17 .[citado 2025 abr. 27 ] Available from: https://doi.org/10.3389/fimmu.2024.1282754.
Artigo de periodico
Measles vaccination in Brazil: where have we been and where are we headed? (2023)
Sato, Ana Paula Sayuri ; Boing, Alexandra Crispim ; Almeida, Rosa Livia Freitas de ; Xavier, Mariana Otero ; Moreira, Rafael da Silveira ; Martinez, Edson Zangiacomi ; Manitto, Alicia Matijasevich ; Donalisio, Maria Rita
Source: Ciencia & saude coletiva. Unidades: FSP, FMRP, FM
Subjects: COVID-19, VACINAS VIRAIS, SARAMPO, ADESÃO À MEDICAÇÃO
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
SATO, Ana Paula Sayuri et al. Measles vaccination in Brazil: where have we been and where are we headed?. Ciencia & saude coletiva, v. 28, n. 2, p. 351-362, 2023Tradução . . Disponível em: https://observatorio.fm.usp.br/handle/OPI/53042. Acesso em: 27 abr. 2025.
APA
Sato, A. P. S., Boing, A. C., Almeida, R. L. F. de, Xavier, M. O., Moreira, R. da S., Martinez, E. Z., et al. (2023). Measles vaccination in Brazil: where have we been and where are we headed? Ciencia & saude coletiva, 28( 2), 351-362. doi:10.1590/1413-81232023282.19172022EN
NLM
Sato APS, Boing AC, Almeida RLF de, Xavier MO, Moreira R da S, Martinez EZ, Manitto AM, Donalisio MR. Measles vaccination in Brazil: where have we been and where are we headed? [Internet]. Ciencia & saude coletiva. 2023 ; 28( 2): 351-362.[citado 2025 abr. 27 ] Available from: https://observatorio.fm.usp.br/handle/OPI/53042
Vancouver
Sato APS, Boing AC, Almeida RLF de, Xavier MO, Moreira R da S, Martinez EZ, Manitto AM, Donalisio MR. Measles vaccination in Brazil: where have we been and where are we headed? [Internet]. Ciencia & saude coletiva. 2023 ; 28( 2): 351-362.[citado 2025 abr. 27 ] Available from: https://observatorio.fm.usp.br/handle/OPI/53042
Artigo de periodico
Heterologous DNA prime- subunit protein boost with Chikungunya virus E2 induces neutralizing antibodies and cellular-mediated immunity (2023)
Coirada, Fernanda Caroline ; Fernandes, Edgar Ruz ; Mello, Lucas Rodrigues de ; Schuch, Viviane ; Campos, Gúbio Soares ; Carla Torres Braconi ; Rosa, Daniela Santoro ; Boscardin, Silvia Beatriz
Source: International Journal of Molecular Sciences. Unidades: ICB, FCF
Subjects: PARASITOLOGIA, ANTICORPOS, LINFÓCITOS T, IMUNOLOGIA CELULAR, VÍRUS CHIKUNGUNYA, VACINAS VIRAIS, PROTEÍNAS RECOMBINANTES, ADJUVANTES IMUNOLÓGICOS, GLICOPROTEÍNAS, IMUNOGENICIDADE DA VACINA, CAMUNDONGOS, CÉLULAS DENDRÍTICAS, EPITOPOS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
COIRADA, Fernanda Caroline et al. Heterologous DNA prime- subunit protein boost with Chikungunya virus E2 induces neutralizing antibodies and cellular-mediated immunity. International Journal of Molecular Sciences, v. 24, p. 1-22, 2023Tradução . . Disponível em: https://doi.org/10.3390/ijms241310517. Acesso em: 27 abr. 2025.
APA
Coirada, F. C., Fernandes, E. R., Mello, L. R. de, Schuch, V., Campos, G. S., Carla Torres Braconi,, et al. (2023). Heterologous DNA prime- subunit protein boost with Chikungunya virus E2 induces neutralizing antibodies and cellular-mediated immunity. International Journal of Molecular Sciences, 24, 1-22. doi:10.3390/ijms241310517
NLM
Coirada FC, Fernandes ER, Mello LR de, Schuch V, Campos GS, Carla Torres Braconi, Rosa DS, Boscardin SB. Heterologous DNA prime- subunit protein boost with Chikungunya virus E2 induces neutralizing antibodies and cellular-mediated immunity [Internet]. International Journal of Molecular Sciences. 2023 ; 24 1-22.[citado 2025 abr. 27 ] Available from: https://doi.org/10.3390/ijms241310517
Vancouver
Coirada FC, Fernandes ER, Mello LR de, Schuch V, Campos GS, Carla Torres Braconi, Rosa DS, Boscardin SB. Heterologous DNA prime- subunit protein boost with Chikungunya virus E2 induces neutralizing antibodies and cellular-mediated immunity [Internet]. International Journal of Molecular Sciences. 2023 ; 24 1-22.[citado 2025 abr. 27 ] Available from: https://doi.org/10.3390/ijms241310517

USP Schools

ReP

Filtros

Document Types

USP Schools

Departament

Authors

USP affiliated authors

Date published

Subjects

Source title

Publisher

Conference titles

Countries/Territories

Grupo de pesquisa

Funding Agencies

Indexado em

Normalized affiliation

Non normalized affiliation

Countries of institutions of collaboration

Área de concentração

Sigla do Departamento/Programa de Pós Graduação

Departamento/Programa de Pós Graduação